CI vs SPRB · P/E 2.4, rev $274.90B vs rev $4.9M
Cigna Corp (CI) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the CI and SPRB stock pages for the full models.
Not investment advice.